News About: Pharm. Industry
Bio stocks emerge as leading theme
Bio-related stocks, including Diostech and Celltrion, have rallied as more foreigners are replacing institutional investors to lead the bullish trend of the tech-heavy Kosdaq.
According to FnGuide, an online financ...
Global management, R&D to drive up Green Cross
The fresh aim of Green Cross Corporation (GCC) is to solidify its position overseas and widen research and development in the life sciences industry.
GCC plan to achieve 2 trillion won in annual sales by 2012 with ...
Yuhan’s baby powder gaining popularity
Yuhan Corporation says its baby powder Sweeter (zinc oxide) has recently gained momentum as it has no talc contaminated asbestos.
A company official said the product has run out of stock due to higher demand from t...
Mypharm eyes 60% share in placenta market
For Mypharm, 2008 is a significant year for another reason.
Its Melsmon placenta injection has achieved a bigger market share, backed by better efficacy and safety, since March.
Industry sources generally agree ...
AZK names new executive managing director
AstraZeneca Korea said that former Lilly Korea Vice President Lee In-hee, 46, was appointed as the new executive managing director to lead its Specialty Care unit (oncology and psychiatry) as well as strategic plannin...
Trading asset-backed securities are available in pharmaceutical industry
Starep Corporation announced that it has developed a new asset-backed security (ABS) to pool the underlying assets of 30 billion won in the account receivables of pharmaceutical firms.
The company said that pooling...
13 original drugs to be lowed by 20%
The insurance prices of 13 original medicines will be reduced from April 15, according to the Ministry of Health, Welfare and Family Affairs.
These medicines subject to price-cut include Handok Pharm’s Actonel (ris...
Company’s preference to ethical business hurts OTC salespersons
Drugmakers are seeking a breakthrough in their sluggish sales by promoting hospital-oriented salespersons while ignoring the morale of OTC salespersons.
Analysts say pharmaceutical firms' keen attention in the hosp...
Dong-A embarks on antibiotic production at new plant
Dong-A Pharm said on April 2 it has completed a new GMP plant producing epirubicin and other antibiotics.
The plant was built on some 3,000 square meters of land at Banwoel Industrial Complex of Ansan City and its ...
Daewoong wins Albis patent dispute
Daewoong Pharm is expected to achieve more stable revenue in the sale of Albis, a ranitidine product plus bismuth and sucralfate, by winning its patent dispute.
The Korean Intellectual Property Tribunal ruled on M...
